US equities |
NVDA $237.88 ▲+1.68% SPCX $167.83 ▲+5.58% MU $1,062.60 ▼-1.14% TSLA $379.19 ▲+2.32% MSFT $524.95 ▲+1.43% SNDK $1,709.66 ▼-0.60% INTC $116.91 ▼-2.03% META $742.18 ▲+1.94%
FinancialContent

Nemaura Medical Inc. - Common Stock (NQ:NMRD)

0.1053 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nemaura Medical Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Nemaura Appoints New COO In Readiness For Manufacturing, Distribution Scale-Up ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD) recently... 
Via Benzinga
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Financial Results, Business Updates for Q3 2022
Via Investor Brand Network
Topics Artificial Intelligence
Nemaura (NASDAQ: NMRD) Appoints New COO in Readiness for Manufacturing, Distribution Scale-Up
Via Investor Brand Network
News headline image
Nemaura Marks History-Making Milestone With Initial Shipment Of CGM Devices ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Appoints New COO in Readiness for Manufacturing and Distribution Scale-Up, Commercialization Phase of Growth
Via Investor Brand Network
News headline image
Nemaura Set To Capitalize On Glucose Monitoring's Exponential Growth Rate ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. The blood glucose monitoring system sector is expected to grow... 
Via Benzinga
Nemaura (NASDAQ: NMRD) Set to Capitalize on Glucose Monitoring’s Exponential Growth Rate
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Set to Capitalize on Glucose Monitoring Sector’s Exponential Growth Rate
Via Investor Brand Network
News headline image
Nemaura Commences Rollout Of Miboko Application ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Nemaura (NASDAQ: NMRD) Commences Rollout of Miboko Application
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Miboko Launch Leveraging ‘Most Reliable Gateway Toward Wider Adoption of Preventative Health Maintenance Practices’
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Nemaura Medical Appoints Healthcare Specialist Dr. Arash Ghadar as COO ↗
NMRD appoints UK-based Dr. Arash Ghadar as Chief Operating Officer, brings decades of healthcare and technology experience Dr. Ghadar previously supervised product development lifecycles, feasibility... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Appoints Healthcare Specialist Dr. Arash Ghadar as COO
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Appoints Technical Healthcare Specialist Dr. Arash Ghadar as COO
Via Investor Brand Network
Nemaura (NASDAQ: NMRD) Marks History-Making Milestone with Initial Shipment of CGM Devices
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Marks History Making Milestone with Initial Shipment of CGM Devices
Via Investor Brand Network
News headline image
Nemaura Medical Commences Rollout of Miboko Application ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical is a medical technology... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Commences Rollout of Miboko Application
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Commence Rollout of Their Miboko Application; Company Targets Employers & Insurers to Ensure Broad Commercial Distribution
Via Investor Brand Network
News headline image
Nemaura Medical Firmly Positioned in Growing Diabetes Tech Market ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Diabetes tech market expanded in 2021... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Firmly Positioned in Growing Diabetes Tech Market
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Firmly Positioned in Growing Diabetes Tech Market With Recent CGM Shipment to UK Licensee
Via Investor Brand Network
News headline image
Nemaura Medical Launches Miboko – A New Metabolic Health Program ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Launches Miboko – A New Metabolic Health Program
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Launches Miboko – a New Metabolic Health Program
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Nemaura Medical Names Industry Veteran as COO ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Names Industry Veteran as COO
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Names Industry Veteran as COO
Via Investor Brand Network
News headline image
Nemaura Medical to Present at H.C. Wainwright Bioconnect Conference ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) to Present at H.C. Wainwright Bioconnect Conference
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9 Next >